scholarly journals Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives

2019 ◽  
Vol 15 (11) ◽  
pp. 2624-2636 ◽  
Author(s):  
Gaël Dos Santos
Keyword(s):  
Influenza Vaccination ◽  
Lessons Learned ◽  
Future Perspectives ◽  
Safety Surveillance

Lessons Learned and Future Perspectives

2021 ◽  
pp. 295-319
Author(s):  
Antonio Vittorino Gaddi ◽  
Michele Nichelatti ◽  
Enrico Cipolla
Keyword(s):  
Lessons Learned ◽  
Future Perspectives

Participant centred safety surveillance of health care workers receiving influenza vaccination

Vaccine ◽  
2019 ◽  
Vol 37 (18) ◽  
pp. 2427-2429 ◽  
Author(s):  
P. Cashman ◽  
S. Moberley ◽  
K. Chee ◽  
J. Stephenson ◽  
S. Chaverot ◽  
...  
Keyword(s):  
Health Care ◽  
Influenza Vaccination ◽  
Health Care Workers ◽  
Safety Surveillance ◽  
Care Workers

Irrigation Development in Uganda: Constraints, Lessons Learned, and Future Perspectives

2017 ◽  
Vol 143 (5) ◽  
pp. 04017003 ◽  
Author(s):  
Joshua Wanyama ◽  
Herbert Ssegane ◽  
Isaya Kisekka ◽  
Allan John Komakech ◽  
Noble Banadda ◽  
...  
Keyword(s):  
Lessons Learned ◽  
Future Perspectives ◽  
Irrigation Development

scholarly journals Pharmaceutical compounding: Recent advances, lessons learned and future perspectives

2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Angeliki Siamidi ◽  
Νatassa Pippa ◽  
Costas Demetzos
Keyword(s):  
Lessons Learned ◽  
Future Perspectives ◽  
Recent Advances

scholarly journals Immunotherapies for pediatric cancer: current landscape and future perspectives

2019 ◽  
Vol 38 (4) ◽  
pp. 573-594 ◽  
Author(s):  
Brian Hutzen ◽  
Siddhi Nath Paudel ◽  
Meisam Naeimi Kararoudi ◽  
Kevin A. Cassady ◽  
Dean A. Lee ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Drug Administration ◽  
Pediatric Cancer ◽  
Positive Impact ◽  
Mechanisms Of Action ◽  
Lessons Learned ◽  
Childhood Cancers ◽  
Future Perspectives ◽  
The Us ◽  
Near Future

AbstractThe advent of immunotherapy has revolutionized how we manage and treat cancer. While the majority of immunotherapy-related studies performed to date have focused on adult malignancies, a handful of these therapies have also recently found success within the pediatric space. In this review, we examine the immunotherapeutic agents that have achieved the approval of the US Food and Drug Administration for treating childhood cancers, highlighting their development, mechanisms of action, and the lessons learned from the seminal clinical trials that ultimately led to their approval. We also shine a spotlight on several emerging immunotherapeutic modalities that we believe are poised to have a positive impact on the treatment of pediatric malignancies in the near future.

Sign in / Sign up

Export Citation Format

Share Document